Journal Of Nuclear Medicine

Journal Of Nuclear Medicine

核医学杂志

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《Journal Of Nuclear Medicine》是由Society of Nuclear Medicine and Molecular Imaging出版社于1960年创办的英文国际期刊(ISSN: 0161-5505,E-ISSN: 2159-662X),该期刊长期致力于核医学领域的创新研究,主要研究方向为医学-核医学。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.1135...%),以发表核医学领域等方向的原创性研究为核心(研究类文章占比99.24%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在264篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Journal Of Nuclear Medicine审稿周期约为约1.0个月。该刊近年未被列入国际预警名单,年发文量约264篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 264 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
1区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
1区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
2区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
1区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 8 / 217

96.5

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 4 / 217

98.39

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 7 / 213

96.9

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 3 / 213

98.83

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 6 / 204

97.3

学科:RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING SCIE Q1 3 / 204

98.77

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:13.6 SJR:2.726 SNIP:2.153
学科类别 分区 排名 百分位
大类:Medicine 小类:Radiology, Nuclear Medicine and Imaging Q1 11 / 361

97%

期刊发文

  • Critical Evaluation of HER2 PET Imaging in Metastatic Breast Cancer: Addressing Key Challenges and Future Direction

    Author: Song, Jiaming; Ye, Jiani

    Journal: JOURNAL OF NUCLEAR MEDICINE. 2026; Vol. 67, Issue 2, pp. 324-324. DOI: 10.2967/jnumed.125.271101

  • Phase 1 Study of [177Lu]Lu-NeoB in Patients with Advanced Solid Tumors Overexpressing Gastrin-Releasing Peptide Receptor: Preliminary Safety and Dosimetry Result

    Author: Mittra, Erik S.; Solnes, Lilja B.; van der Veldt, Astrid A. M.; Wong, Jeffrey; Heinrich, Michael C.; Aloj, Luigi; Chen, Christopher T.; Rowe, Steven P.; Brabander, Tessa; Pacey, Simon; Aimone, Paola; Pathak, Dhrubajyoti; Blumenstein, Lars; Liu, Yongmin; Iagaru, Andrei

    Journal: JOURNAL OF NUCLEAR MEDICINE. 2026; Vol. 67, Issue 2, pp. 262-268. DOI: 10.2967/jnumed.125.270411

  • First-in-Human PET Imaging of Prostate Cancer Using [68Ga]Ga-AZ-093 and Its Nitroimidazole-Conjugated Derivative [68Ga]Ga-AZ-NI-09

    Author: Wang, Guochang; Lai, Yuxin; Chen, Dongning; Jin, Wenbin; Luo, Yang; Peng, Yumeng; Kung, Hank F.; Zhu, Lin; Zang, Jie; Xu, Ning; Miao, Weibing

    Journal: JOURNAL OF NUCLEAR MEDICINE. 2026; Vol. 67, Issue 1, pp. 105-112. DOI: 10.2967/jnumed.125.270703

  • The Role of Estrogen Receptor-Targeted PET with 16α-18F-Fluoro-17β-Estradiol in Predicting Response to Endocrine Therapies in Metastatic Breast Cancer: A Metaanalysi

    Author: Specht, Jennifer M.; van Geel, Jasper J. L.; Song, Shaoli; Liu, Cheng; Hippe, Daniel S.; Digregorio, Nicholas A.; Brand, Christine J.; Linden, Hannah M

    Journal: JOURNAL OF NUCLEAR MEDICINE. 2026; Vol. 67, Issue 1, pp. 36-42. DOI: 10.2967/jnumed.125.270763

  • 68Ga-FAPI-04 PET for Detecting Occult Peritoneal Metastasis in Locally Advanced Gastric Cancer: Diagnostic Performance and Cost Analyses in a Single-Center, Prospective Cohort Stud

    Author: Hu, Qiancheng; Zhang, Shunyu; Yang, Kun; Yin, Yuan; Chen, Xiaolong; Wang, Mojin; Zhang, Bo; Zhuang, Wen; Liu, Ming; Shen, Chaoyong; Zhang, Pengfei; Dai, Hongyuan; Cheng, Junjun; Ji, Shuming; Su, Minggang; Gou, Hongfeng; Hu, Jiankun

    Journal: JOURNAL OF NUCLEAR MEDICINE. 2026; Vol. 67, Issue 1, pp. 53-59. DOI: 10.2967/jnumed.125.270633

  • Dansylated Amino Acid-Modified Long-Acting PSMA Derivatives 68Ga/177Lu-LNC1011 as Prostate Cancer Theranostic

    Author: Yang, Hongzhang; Wang, Jiarou; Wen, Xuejun; Guo, Huifeng; Jakobsson, Vivianne; Zhao, Tianzhi; Zeng, Fantian; Shen, Huaxiang; Zhang, Heng; Liu, Xiaomin; Qin, Yatong; Li, Xinyi; Xiong, Hehe; Zhou, Zijian; Zhang, Jingjing; Chen, Xiaoyuan

    Journal: JOURNAL OF NUCLEAR MEDICINE. 2025; Vol. 66, Issue 5, pp. 739-747. DOI: 10.2967/jnumed.124.268959

  • Additive Value of [68Ga]Ga-RM26 PET/CT to [68Ga]Ga-PSMA-617 PET/CT in Detecting Pelvic Lymph Node Metastasis in Prostate Cancer: A Prospective, Single-Center, Phase II Stud

    Author: Tang, Wei; Qi, Lin; Chen, Minfeng; Zhang, Ye; Tang, Yongxiang; Hu, Shuo; Gao, Xiaomei; Cai, Yi

    Journal: JOURNAL OF NUCLEAR MEDICINE. 2025; Vol. 66, Issue 5, pp. 719-725. DOI: 10.2967/jnumed.124.269189

  • [99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Stud

    Author: Sun, Yining; Hao, Zhixin; Gao, Hannan; Yang, Guangjie; Pan, Bo; Zhu, Min; Wan, Yakun; Shi, Jiyun; Huo, Li; Chen, Haojun; Wang, Fan

    Journal: JOURNAL OF NUCLEAR MEDICINE. 2025; Vol. 66, Issue 4, pp. 543-551. DOI: 10.2967/jnumed.124.268564